Doctors rename difficult to treat condition PCOS, saying term is ‘inaccurate' and ‘misleading'

Medical professionals have announced a change in the terminology used to describe polycystic ovary syndrome (PCOS), which affects over 170 million women globally. The condition will now be referred to as polyendocrine metabolic ovarian syndrome (PMOS), as doctors argue that the previous name was inaccurate and contributed to delays in treatment. This rebranding aims to better reflect the complex hormonal and metabolic issues associated with the condition, potentially improving patient care and understanding. The decision underscores the need for clarity in medical terminology to enhance diagnosis and management of the syndrome.

Read More